Depression and Anxiety Trial, Recruiting NCT06977178 Sponsor: University of North Carolina, Chapel Hill Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT06977178
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are male or female and between 12 and 14 years old
  • People who are experiencing symptoms of anxiety
  • People who are able to understand and sign an assent form, and whose parents are able to sign a permission and consent document in English
  • People who meet the trial's specific hearing and vision requirements (confirm with trial site)
  • People who have never used substances such as alcohol, tobacco, or marijuana

Who may not be able to join:

  • People who have metal objects or implants in their body, such as bone screws, shunts, or body piercings that cannot be removed
  • People who have been diagnosed with psychosis or a severe emotional disturbance
  • People who have used alcohol, tobacco, or marijuana more than 3 times
  • Girls who are pregnant — the trial site will not include them in the stress evaluation or MRI scan
  • People who are currently taking medications that directly affect how the heart and blood vessels work, such as beta blockers like propranolol
  • People who are currently taking, or have ever taken, antipsychotic medication
  • People who have had a head injury that caused them to lose consciousness for more than 5 minutes
  • People who are planning to get non-removable metal braces
  • People with significantly impaired intellectual functioning, assessed as a full-scale IQ below 70
  • People with a current or past significant condition affecting the brain or nervous system that could interfere with brain imaging results (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Aysenil Belger, PhD, University of North Carolina, Chapel Hill

Phone: (919)-260-9822‬

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
20 February 2024
Est. completion
30 June 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Reaction time during the functional magnetic resonance imaging (FMRI) Stop Signal Task; Percent signal change during the FMRI Stop Signal Task; Percent signal change activation during the No-stimuli, Predictable-stimuli, and Unpredictable-stimuli (NPU) task; Percent signal change during the Attentional Load Paradigm (ALP) task; Percent signal change during Emotional Face N-Back (EFNBack); Sympathetic and Parasympathetic nervous system ECG activation or heart rate variability (HRV) during a psychosocial stressful task (Trier Social Stress Test - TSST); Endocrine (cortisol) measures during a psy...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov